AstraZeneca says Forxiga approved in EU for heart failure By: MarketWatch February 07, 2023 at 03:11 AM EST AstraZeneca PLC said Tuesday that Forxiga has been approved in the European Union for the treatment of symptomatic chronic heart failure. Read More >> Related Stocks: Astrazeneca Plc ADR